Yong Li

Yong Li is an Assistant Research Professor at Loma Linda University School of Medicine, Pharmacology Division. With an MD and PhD, his work focuses on the effects of prenatal exposures on offspring health, particularly in Reproductive Toxicology and Molecular Pharmacology. He holds a PhD from Loma Linda University.

• Education: PhD, Loma Linda University

His research explores fetal programming, epigenetic modifications, and signaling pathways linked to prenatal stressors like nicotine, hypoxia, and diabetes. Key findings include nicotine-induced ischemic heart injury, microRNA-210's role in neuroinflammation, and glucocorticoid receptor interactions in brain injury.

Over 15 recent publications (2011-2024) highlight his expertise in neonatal brain injury, oxidative stress, and transcriptomic changes. Notably, his 2024 work on maternal e-cigarette exposure and gestational diabetes underscores long-term epigenetic consequences. He has received recognition in 2013 for unspecified scientific contributions.